PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112

Cancer Letters

Volumn 168, Issue 1, 2001, Pages 37-43

  Bahrenberg, Gregor ^a   Brauers, Andreas ^a   Joost, Hans Georg ^a   Jakse, Gerhard ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Gene expression; Phorbol ester; Prostate stem cell antigen; RT112 cells

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; MEMBRANE PROTEIN; MESSENGER RNA; PHORBOL ESTER; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROSTATE STEM CELL ANTIGEN; PROTEIN KINASE C; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL ADHESION; CELL AGGREGATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PH; PRIORITY JOURNAL; TUMOR GROWTH; UNDIFFERENTIATED CARCINOMA;

BLOTTING, NORTHERN; CELL ADHESION; CYCLOHEXIMIDE; CYTOKINES; DACTINOMYCIN; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HUMANS; HYDROGEN-ION CONCENTRATION; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; PHORBOL ESTERS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER NEOPLASMS;

EID: 0035838583     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00497-9     Document Type: Article

References (19)

1. Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., LeBeau M.M., Loda M., Witte O.N. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA. 95:1998;1735-1740.
2. Dannull J., Diener P.A., Prikler L., Fürstenberger G., Cerny T., Schmid U., Ackermann D.K., Groettrup M. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res. 60:2000;5522-5528.
3. Saffran D.C., Raitano A.B., Hubert R.S., Witte O.N., Reiter R.E., Jakobovits A. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc. Natl. Acad. Sci. USA. 98:2001;2658-2663.
4. Gu Z., Thomas G., Yamashiro J., Shintaku I.P., Dorey F., Raitano A., Witte O.N., Said J.W., Loda M., Reiter R.E. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene. 19:2000;1288-1296.
5. Bahrenberg G., Brauers A., Joost H.G., Jakse G. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem. Biophys. Res. Commun. 275:2000;783-788.
6. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
7. Nutting C., Chowaniec J. Evaluation of the actions and interactions of retinoic acid and epidermal growth factor on transformed urothelial cells in culture: implications for the use of retinoid therapy in the treatment of bladder cancer patients. Clin. Oncol. 4:1992;51-55.
8. Masters J.R.W., Hepburn P.J., Walker L., Highman W.J., Trejdosiewicz L.K., Povey S., Parkar M., Hill B.T., Riddle P.R., Franks L.M. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res. 46:1986;3630-3636.
9. Marshall C.J., Franks L.M., Carbonell A.W. Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J. Natl. Cancer Inst. 58:1977;1743-1751.
10. Rohde D., Raffenberg G., Kaviani S., Wolff J., Jakse G. 7-N-(2-([2-(Gamma-L-glutamylamino)-ethyl]-dithio)-ethyl)-mitomycin C (KW-2149) is more active than mitomycin C on chemonaive and drug-resistant urothelial carcinoma cells. Urol. Res. 26:1998;243-247.
11. Wang M.-R., Perissel B., Malet P. Cytogenetic characterization of a bladder carcinoma cell line by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 82:1995;170-174.
12. Reiter R.E., Sato I., Thomas G., Qian J., Gu Z., Watabe T., Loda M., Jenkins R.B. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Genes Chromosomes Cancer. 27:2000;95-103.
13. Ashendel C.L. The phorbol ester receptor: a phospholipid regulated protein kinase. Biochim. Biophys. Acta. 822:1985;219-242.
14. Holguin M.H., Martin C.B., Weis J.H., Parker C.J. Enhanced expression of the complement regulatory protein, membrane inhibitor of reactive lysis (CD59), is regulated at the level of transcription. Blood. 82:1993;968-977.
15. Philbrick W.M., Palfree R.G.E., Maher S.E., Bridgett M.M., Sirlin S., Bothwell A.L.M. The CD59 antigen is a structural homologue of murine LY-6 antigens but lacks interferon inducibility. Eur. J. Immunol. 20:1990;87-92.
16. Dumont F.J., Altmeyer A., Staruch M.J., Dijkmans R., Palfree R.G., Fischer P.A. Role of protein kinase C in IFN-mediated LY-6E antigen induction. J. Immunol. 144:1990;3795-3803.
17. Brakenhoff R.H., Gerretsen M., Knippels E.M.C., van Dijk M., van Essen H., Weghuis D.O., Sinke R.J., Snow G.B., van Dongen G.A.M.S. The human E48 antigen, highly homologous to the murine LY-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. J. Cell Biol. 129:1995;1677-1689.
18. Schrijvers A.H.G., Gerretsen M., Fritz J.M., van Walsum M., Quak J.J., Snow G.B., van Dongen G.A.M.S. Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Exp. Cell Res. 196:1991;264-269.
19. Noda S., Kosugi A., Saitoh S., Narumiya S., Hamaoka T. Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2. J. Exp. Med. 183:1996;2355-2360.